Rohit K. Jain, MB, BS, MD

Rohit K. Jain, MB, BS, MD, of Weill Cornell Medicine

Articles by Rohit K. Jain, MB, BS, MD

Erdafitinib With EV Following Platinum, PD-1/L1 Inhibitors for mUC with FGFR3/2 Alterations

Rohit K. Jain, MB, BS, MDUrothelial Carcinoma | February 20, 2025

Dr. Jain spoke to the rationale for combining erdafitinib with EV in mUC patients with FGFR3/2 genetic alterations.